All companies
Visit website
CAREMINDr
OperatingCAREMINDr Corporation
Healthcare · Technology · Founded 2017
Transforming the way patients receive care
Post-money valuation ⓘ
$35.5M
As of Sep 2022 · from CAREMINDr Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$239,702
Across 1 round since 2022
Latest share price
$1.48
CAREMINDr Common Stock 1 offering price
Financials
FY2020–FY2025 · from SEC filings · hover any figure for its source$1K
−$1.4M
2020
$64K
−$808K
2021
$376K
−$747K
2022
$488K
−$701K
2023
$454K
−$549K
2024
$423K
−$735K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$1,365
$64,413
$376,103
$488,084
$453,535
$423,058
Cost of goods sold
$33,302
$4,432
$120,052
$127,500
$32,350
$128,000
Gross margin
-2340%
93%
68%
74%
93%
70%
Net income
-$1,372,552
-$807,561
-$747,371
-$701,148
-$549,051
-$734,768
Taxes paid
$919
$800
$800
$0
$34,981
$37,967
Balance sheet
Cash
$161,061
$61,857
$182,680
$123,718
$66,905
$31,089
Accounts receivable
$144
$18,004
$42,865
$13,060
$0
$8,488
Total assets
$161,205
$79,861
$225,545
$137,814
$135,831
$128,477
Short-term debt
$12,780
$187,132
$145,000
$450,924
$1,007,474
$1,619,130
Long-term debt
$3,055,500
$3,598,167
$3,625,500
$4,045,500
$0
$4,659,500
Total liabilities
$3,068,280
$3,785,299
$3,770,500
$4,496,424
$1,007,474
$6,278,630
Other
Headcount
—
10
10
10
—
10
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$35.5M
post-money
CAREMINDr Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $239.7K / $1MInvestors 211Post-money $35.5M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 3 of 4 annual reports (FY2022–FY2025)
211 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 9 filings on EDGARSource: ManualCIK 0001738419Share price $1.48
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.